REVIEW- ADVANCE TECHNIQUE IN OCULAR DRUG DELIVERY SYSTEM
Shravan Kumar Paswan*, Pritt Verma, Mahendra Singh Yadav, Debjit Bhowmik, Shyam Sundar Gupta, Lubna Azmi, Ila Shukla, Kalali Bhargava Ch.V.Rao
ABSTRACT
Eye diseases are commonly encountered in day to day life, which are
cured or prevented through the conventionally used dosage forms like
eye drops, ointments. Delivery to the internal parts of the eye still
remains troublesome due to the anatomical and protective structure of
the eye. Ophthalmic drug delivery is one of the most interesting and
challenging problem facing the pharmaceutical companies in the
market. The major problem associated with the conventional dosage
forms is the bioavailability of drug. Poor bioavailability of ophthalmic
solutions caused by dilution and drainage from the eye can be
overcome by using in-situ-forming ophthalmic drug delivery systems
prepared from polymers that exhibit reversible liquid-gel phase
transition. To overcome these problems various types of dosage forms
such as nanoparticles, liposomes and microemulsions have been
developed. Controlled drug delivery systems offer many advantages
over conventional dosage forms in terms of improving drug
bioavailability, reducing toxicity and decreasing dosage frequency. Newer research in
ophthalmic drug delivery systems is directed towards a amalgamation of several drug
delivery technologies, that includes to build up systems which is not only extend the contact
time of the vehicle at the ocular surface, but which at the same time slow down the removal
of the drug This review focuses on recent development in conventional and non-conventional
ophthalmic dosage formulation and products used to achieve prolonged contact time of drugs with the cornea and increase their bioavailability and different technique and products for
both mode of delivery.
Keywords: ophthalmic drugs, liposomes, nanoparticles, eye drops, ointments.
[Download Article]
[Download Certifiate]